16 March 2018 EMA/CVMP/141912/2018 Committee for Medicinal Products for Veterinary Use

MRL summary opinion 1

Isoflurane Porcine species

On 15 March 2018, the Committee for Medicinal Products for Veterinary Use (CVMP) adopted an opinion 2 recommending the establishment of MRLs for isoflurane in porcine species and amending the existing entry for Equidae with regard to the ‘Other provisions’ in Table 1 (Allowed substances) of the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009, in accordance with the following table: Pharmaco

Marker

Animal

-logically

residue

species

NOT

Equidae

Target

Other

Therapeutic

tissues

provisions

classification

No MRL

NOT

For use by

General

required

APPLICABLE

inhalation

anaesthetics

No MRL

NOT

For use by

required

APPLICABLE

inhalation in

MRLs

active substance Isoflurane

APPLICABLE Porcine

piglets up to 7 days of age.

1

Summaries of opinion are published without prejudice to the Commission Decision. Applicants may request re-examination of any CVMP opinion, provided they notify the European Medicines Agency in writing of their intention to request such re-examination within 15 days of receipt of the opinion 2

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.